(Axios) – The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease symptoms of Parkinson’s disease, which affects nearly 1 million people in the United States. Why it matters: Medtronic, the device’s manufacturer, said this will be the largest-ever commercial rollout of brain-computer interface technology. (Read More)